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Abstract Photoreleasable molecules are important in studies of 
various biological phenomena, especially cell signaling. Here we 
report a generally applicable approach for 'caging' unprotected 
cysteine-containing or thiophosphorylated peptides in aqueous 
solution with 2-nitrobenzyl bromides. Photolysis of the caged 
peptides was achieved with near UV light with product quantum 
efficiencies of 0.06-0.62 under conditions that produced no 
damage to attendant biological macromolecules. Yields of 
uncaged peptides were 55-70%. Selective reaction of the side-
chain of thiophosphoryl serine with 2-nitrobenzyl bromide in the 
presence of a cysteinyl residue was also demonstrated, establish-
ing a means for functional caging of various signal transduction 
proteins without prior modification or mutagenesis. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The photorelease ('uncaging') of reagents by chemical bond 
cleavage is widely applied in experimental biology [1-3]. The 
ability to control the time, dose and site of activation of these 
reagents by photolysis is a tremendous advantage. Abundant 
work on caged small molecules has appeared, e.g. caged Ca 2 + 
[4], N O [5], CO [6], nucleotides [7], neurotransmitters [8] and 
amino acids [9]. Caged fluorophores attached to biomolecules 
have been applied to measurements of the active or diffusional 
movement of molecules in biological systems [10]. Photocleav-
able crosslinking reagents and caged biotins have also been 
devised [11-13]. By contrast, relatively little work has been 
done on caged peptides and proteins. 
One approach to caged proteins is random chemical mod-
ification to introduce photocleavable protecting groups [14-
18]. R a n d o m modification can also be used to introduce pho-
toisomerizable groups, which can provide a degree of rever-
sible control of enzyme activity [19]. Targeted modification is 
likely to be more predictable and reproducible, and will be 
essential for caging single domains in multifunctional pro-
teins. Caged proteins, such as lysozyme, have been made by 
the incorporation of unnatural amino acids at specific sites 
during in vitro translation [20]. This technique has recently 
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been used to initiate protein splicing from a caged precursor 
[21]. A second rational approach to the photoregulation of 
enzymes involves derivatization with an active-site directed 
reagent. For example, the protease thrombin can be acylated 
on the active site serine with an o-hydroxycinnamoyl group 
that is stable until irradiated, when it undergoes trans-cis iso-
merization. Thermal deacylation follows by lactonization of 
the leaving group [22,23]. A third approach is targeted chem-
ical modification of single cysteine residues [24,25], which can 
be introduced by genetic engineering [24]. We have reported 
the use of 2-bromo-2-(2-nitrophenyl)acetic acid (BNPA) to 
cage an engineered staphylococcal oc-hemolysin and produce 
a photoactivatable pore-forming protein [24]. Caged heavy 
meromyosin has been produced by selective derivatization of 
one of two natural cysteines with 4,5-dimethoxy-2-nitrobenzyl 
bromide (DMNBB) [25]. 
Less work still has been done on caged peptides. 5-Nitro-
benzyl cysteine [26] and many similarly blocked amino acids 
[27] have been produced for peptide synthesis and might be 
used to make caged peptides. Reversible alterations in peptide 
conformation can be obtained by incorporating photoisomer-
izable groups [28]. Here, we report a general approach to 
caging peptides by reacting various 2-nitrobenzyl bromides 
at the sulfur a toms of cysteine or thiophosphoryl serine 
(Fig. 1). The caged peptides are efficiently photolyzed by 
UV light to regenerate the uncaged form. Because the caging 
chemistry is performed in aqueous solution, the procedures 
should be applicable to proteins, including phosphorylatable 
components of signal transduction pathways. 
2. Materials and methods 
2.1. Materials 
Kemptide (LRRASLG) was purchased from Peninsula Laborato-
ries. C-Kemptide (LRRACLG) was synthesized at the WFBR Protein 
Chemistry Facility. Kemptide CS-dimer (LRRACLGLRRASLG) was 
synthesized by Quality Controlled Biochemicals and further purified 
by HPLC. Recombinant murine protein kinase A (PKA) catalytic 
subunit was kindly provided by Dr. Susan Taylor (University of Cal-
ifornia, San Diego). Adenosine 5'-0-(3-thiotriphosphate) (ATP(y)S) 
was purchased from Calbiochem-Novabiochem Corp. and phage X 
protein phosphatase (A,-PPase) from New England BioLabs. 2-Bro-
mo-2-(2-nitrophenyl)acetic acid (BNPA) was synthesized previously 
[24] and is now available from Molecular Probes. 2-Nitrobenzyl bro-
mide (NBB) was purchased from Fluka and 4,5-dimethoxy-2-nitro-
benzyl bromide (DMNBB) from Aldrich. l-(2-Nitrophenyl)ethyl 
phosphate was purchased from Molecular Probes as the diammonium 
salt. 
2.2. Mass spectrometry 
Mass spectrometry was performed with a PerSeptive Voyager ma-
trix-assisted laser desorption/ionization mass spectrometer (MALDI-
MS) equipped with a 337 nm nitrogen laser. The analyte samples in 
~ 2 5 % acetonitrile/0.1% TFA or in a low salt buffer solution (0.6 ul) 
were spotted onto the sample plate, prior to the addition of a satu-
rated matrix solution: a-cyano-4-hydroxycinnamic acid in 25% ace-
tonitrile/0.1% TFA (0.6 ul). The sample was dried at room temper-
ature before analysis at a scan rate of 5 s_1 . Electrospray ionization 
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mass spectrometry (ESI-MS) was carried out by the Harvard Micro-
chemistry Facility. 
2.3. Thiophosphorylation of peptides 
Kemptide or kemptide CS-dimer (1 mg) was dissolved in 100 mM 
MOPS, pH 7.0, containing 100 mM KC1 and 10 mM MgCl2 (300 ill). 
ATP(y)S in H2O (300 ul) was added in 5-fold molar excess over pep-
tide. Thiophosphorylation was initiated by the addition of PKA cata-
lytic subunit (2 (il; final concentration of 1.0 iig/ml). Thiophosphory-
lated peptides were purified by HPLC with a Vydac Cis column 
(buffer A: 0.1% TFA in water; buffer B: 0.08% TFA in acetoni-
trile/water (7: 3)) and then analyzed by MALDI-MS. Ions were ob-
served at mlz 869 and 1638, corresponding to the [M+1H]+ protona-
tion states of monomeric thiophosphoryl kemptide and kemptide CS-
dimer, respectively. Purified thiophosphorylated peptides were lyophi-
lized and stored at —20°C. 
2.4. Synthesis of caged peptides 
The reactions of C-kemptide (0.5 mM) with caging reagents, NBB, 
DMNBB, and BNPA, were carried out in 100 mM Tris-HCl, pH 7.2, 
at 25°C in the dark for 1 h. Stock solutions (50 mM) of NBB, 
DMNBB, and BNPA were prepared in, respectively, 95% ethanol, 
dimethylformamide, and 100 mM Tris-HCl, pH 7.2. Final concentra-
tion of 2 mM NBB and BNPA, and 1 mM DMNBB were present in 
the reaction mixture. The caged C-kemptides were purified by HPLC 
(see above). Caged thiophosphoryl kemptides were synthesized by 
reaction with NBB and DMNBB under the same conditions used 
for caging C-kemptide. Reaction of thiophosphoryl kemptide with 
BNPA was also carried out in 100 mM sodium acetate buffer, pH 
4.0, at 37°C in the dark for 4 h. Reactions of kemptide CS-dimer (0.5 
mM) or thiophosphoryl kemptide CS-dimer (0.5 mM) with NBB (2 
mM) were carried out in 100 mM Tris-HCl, pH 7.2, at 25°C in the 
dark for 100 min. This yielded kemptide CS-dimer caged on the cys-
teinyl residue (MALDI-MS, miz 1677) and thiophosphoryl kemptide 
CS-dimer caged on both the cysteinyl residue and thiophosphoryl 
serine (MALDI-MS, miz 1909). Selective caging of thiophosphoryl 
kemptide CS-dimer (0.5 mM) with NBB (2 mM) was achieved in 
100 mM sodium acetate buffer, pH 4.0, at 25¡C in the dark for 100 
min. The product was purified by HPLC (MALDI-MS, miz 1774). 
2.5. Photolysis in solution 
Caged peptide (600 ul, 1.6-1.8 mM) in 100 mM sodium acetate 
buffer, pH 5.8, was placed in two wells of a 96-well microplate on 
ice. Irradiation was carried out with a 30 W UV lamp, which was set 
1.5 cm above the plate (2200 (iW cm - 2 , peak emission 312 nm, Cole-
Parmer H-09815-22). A glass filter, providing a window at 290-380 
nm (Oriel #51124), was used in all experiments. Irradiated material 
was removed at various time points and subjected to analysis by 
HPLC. The relative product quantum efficiencies (§) for caged C-
kemptides and thiophosphoryl kemptides were determined by com-
parison to the caged phosphate l-(2-nitrophenyl)ethyl phosphate, 
0 = 0.54 [29,30]. Free phosphate was measured with a kit from 
Sigma Diagnostics. Quantum efficiencies were calculated by using 
V1/V2 = <M<|>2 where v is the rate of photolysis. This equation is valid 
for solutions of high absorbance. 
3. Results 
3.1. Caging C-kemptide with NBB, BNPA, and DMNBB 
Caged C-kemptide was obtained in 95% yield by reaction 
with 2 mM NBB in 100 mM Tris-HCl, pH 7.2, at 25°C for 1 h. 
The caged peptide was purified by HPLC and analyzed by 
MALDI-MS. A peak at mlz 923 corresponded to the +1 
charge state of caged C-kemptide. A second peak at mlz 907 
was presumably due to conversion of the nitro group to a 
nitroso group [31] in the laser beam of the mass spectrometer. 
A third peak at mlz 788 was consistent with uncaged C-kemp-
tide, produced by laser-induced photolysis of the nitrobenzyl 
group. Similarly, C-kemptide could be caged by reaction with 
DMNBB and BNPA with yields of more than 95% (Table 1). 
C-kemptide caged by BNPA appeared as two peaks (both mlz 
966) upon HPLC, corresponding to the diastereomers of oc-
carboxy-2-nitrobenzyl C-kemptide. Laser-induced photolysis 
(both -NO2 -» -NO and uncaging) was also observed in these 
cases. 
3.2. Caging thiophosphoryl kemptide with NBB, BNPA, and 
DMNBB 
Thiophosphoryl kemptide was reacted with NBB under the 
same conditions used for C-kemptide. Caged thiophosphoryl 
kemptide was formed in 95% yield, purified by HPLC and 
analyzed by MALDI-MS. There were two sets of peaks in 
the mass spectrum. One set comprised the major signal at 
mlz 1004, corresponding to the +1 charge state of caged thio-
phosphoryl kemptide, and a peak at mlz 988, which again 
was presumably due to the loss of an O atom from the nitro 
group [31]. The second set of peaks at mlz 869 and 853, 
represented the formation of uncaged thiophosphoryl kemp-
tide (mlz 869), and, presumably, phosphokemptide in which 
the sulfur of the thiophosphoryl group had been exchanged 
for an oxygen atom (mlz 853). When the caged thiophosphor-
yl kemptide was analyzed by ESI-MS, the mlz 1004 peak was 
prominent and the mlz 988, 869 and 853 peaks were absent 
(data not shown), consistent with the view that the latter three 
peaks originated by laser photolysis in the MALDI mass spec-
trometer. Sulfur-oxygen exchange did not occur during pho-
tolysis in solution (see below). Thiophosphoryl kemptide can 
also be caged by DMNBB with a yield of 95%> under the same 
reaction conditions (Table 1). All three peaks corresponding 
to those attributed to photolysis in the case of NB-thiophos-
phoryl kemptide were seen upon MALDI-MS. No reaction 
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Fig. 1. Strategy for caging of cysteinyl and thiophosphoryl peptides, including selective caging of thiophosphoryl peptides in the presence of 
free cysteinyl residues. 
P. Pan, H. BayleyIFEBS Letters 405 (1997) 81-85 83 
Table 1 
Yields for caging of peptides, and yields and quantum efficiencies for photolysis of caged peptides 
Peptide Reagent (%) Yield of 
Caging Photolysis 
♦ 
C-kemptide 
C-kemptide 
C-kemptide 
Thiophosphoryl kemptide 
Thiophosphoryl kemptide 
Thiophosphoryl kemptide 
NBB 
DMNBB 
BNPA 
NBB 
DMNBB 
BNPA 
95 
95 
95 
95 
95 
10 
70 
67 
62 
70 
55 
0.62 
0.15 
0.21 
0.23 
0.06 
occurred between thiophosphoryl kemptide and BNPA at 
neutral or basic pH. Incubation of thiophosphoryl kemptide 
with 2 mM BNPA at pH 4.0, 37°C, for 4 h gave ~ 10% yield 
of the diastereomers of the caged thiophosphoryl kemptide. 
These derivatives were not investigated further due to the low 
yields and the relatively harsh reaction conditions. 
3.3. Selective reaction of thiophosphate in a cysteine-containing 
peptide 
To examine the selective caging of serine thiophosphate in 
the presence of a cysteinyl residue, kemptide CS-dimer 
(LRRACLGLRRASLG), a 14-mer containing one unit of 
C-kemptide and one unit of kemptide, was synthesized and 
thiophosphorylated with ATP(y)S and PKA catalytic subunit. 
When thiophosphoryl CS-dimer was reacted with NBB at pH 
7.2, both the thiophosphate and Cys residue were modified as 
determined by MALDI-MS (mlz 1909) of the HPLC purified 
product. Selective caging of the thiophosphate group was 
achieved in 80%) yield by treatment with 2 mM NBB in 100 
mM sodium acetate buffer at pH 4.0, 25°C, for 100 min. 
MALDI-MS {mlz 1774) of the HPLC purified product was 
consistent with only one nitrobenzyl group per peptide. Thi-
ophosphoryl CS-dimer, caged with NBB at pH 4.0, was di-
gested with trypsin and the fragments were analyzed directly 
by MALDI-MS (Fig. 2). The peak at mlz 734 is consistent 
with the caged thiophosphoryl fragment RASP*LG, and the 
peak at mlz 600 with its uncaged product. This experiment 
clearly demonstrates that, at pH 4.0, thiophosphorylated ser-
ine was selectively caged in the presence of a free cysteinyl 
residue. 
3.4. Photolysis of caged peptides 
The caged peptides were photolyzed in aqueous solution 
with UV light (A,max = 312 nm). At pH 5.8, both NB-C-kemp-
tide and NB-thiophosphoryl kemptide afforded the uncaged 
peptides in ~ 70% yield (Fig. 3). The half-times for release of 
C-kemptide and thiophosphoryl kemptide under our irradia-
tion conditions were 8 and 20 min, respectively. Photolysis 
efficiencies for both NB-C-kemptide and NB-thiophosphoryl 
kemptide were decreased at pH 7.2 (Fig. 3). Photolysis at pH 
5.8 of C-kemptide caged by BNPA and DMNBB released 
uncaged peptide in yields of 62 and 67%, respectively. Thio-
phosphoryl kemptide caged with DMNBB could be photolyti-
cally converted to the uncaged peptide in ~ 55% yield (Table 
1). The relative quantum eificiencies for the photolytic release 
of peptides from caged C-kemptide and thiophosphoryl kemp-
tide were determined by comparison of the rates of photolysis 
of the caged peptides with the rate of photolysis of l-(2-nitro-
phenyl)ethyl phosphate for which $ has been determined to be 
0.54 by the ferrioxalate actinometer method [29,30]. The val-
ues ranged from <|> = 0.06 to 0.62 (Table 1). Product quantum 
efficiencies for the caged thiophosphates l-(2-nitrophenyl)eth-
yl ATP(y)S ($ = 0.49, pH 7.1) and l-(2-nitrophenyl)ethyl 5-
thio-IP3 ($ = 0.57, pH 7.0) are higher than that for NB-caged 
thiophosphoryl kemptide. Nevertheless, the latter can be un-
caged in the presence of protein (see below). No literature 
values for thioethers are available for comparison with NB-
caged C-kemptide. 
3.5. Effect of protein phosphatase on caged thiophosphoryl 
kemptide 
When thiophosphoryl kemptide was incubated with phage 
X protein phosphatase (X-PPase) at 30°C for 3 h, 90% dethio-
phosphorylation occurred as determined by HPLC and MAL-
DI-MS. By contrast, the thiophosphate group of NB-thio-
phosphoryl kemptide was fully protected against A,-PPase 
(Fig. 4). However, when the caged thiophosphoryl kemptide 
was irradiated by UV light for 40 min and then incubated 
with A.-PPase at 30°C for 3 h, ~ 7 0 % dethiophosphorylated 
peptide was found upon HPLC analysis. About 10% of the 
uncaged thiophosphoryl kemptide was not yet dethiophos-
phorylated and about 5% of the caged thiophosphoryl peptide 
was not yet photolyzed. If NB-thiophosphoryl kemptide was 
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Fig. 2. MALDI-MS peptide map of the reaction product between 
thiophosphoryl CS-dimer and NBB at pH 4.O. The derivatized pep-
tide was digested with trypsin (1 ng/ml) in 25 mM NH4HCO3 at 
pH 8.9 for 10 min. Identified tryptic fragments are tabulated, in-
cluding those uncaged by the laser. 
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Fig. 3. Photolysis of NB-caged peptides: (A) NB-caged thiophos-
phoryl kemptide; (B) NB-caged C-kemptide. The caged peptides 
(1.6-1.8 mM) in 100 mM sodium acetate, pH 5.8, or in 100 mM 
Tris-HCl, pH 7.2, were irradiated with UV light. Samples were re-
moved for HPLC analysis at the time points shown: (D) caged pep-
tide, pH 5.8; (0) uncaged peptide, pH 5.8; (o) caged peptide, pH 
7.2. 
mixed with X-PPase and then photolyzed under the same con-
ditions, a ~ 65% yield of dethiophosphorylated kemptide was 
obtained, showing that the enzyme is stable to the irradiation 
conditions (Fig. 4). 
4. Discussion 
We have demonstrated a general approach for caging un-
protected cysteine and thiophosphoryl peptides in aqueous 
solution with 2-nitrobenzyl protecting groups. Further, we 
have shown that thiophosphoryl serine residues can be selec-
tively caged in peptides that contain free cysteine (Fig. 1). 
Both the caged cysteine and thiophosphoryl peptides are ef-
fectively uncaged by near UV light, under conditions that do 
not damage a test protein. 
Two major considerations dictate the choice of sulfhydryl-
directed 2-nitrobenzyl reagents for derivatizing peptides and 
proteins. First is the ability to obtain a high yield of caged 
product. The possibility of carrying out the caging reaction in 
aqueous solution is especially important for proteins. Second, 
the caged reagent should be efficiently photolyzed at wave-
lengths that do not damage biological molecules. With the 
first consideration in mind, we previously synthesized the 
highly water-soluble BNPA [24]. However, while BNPA reacts 
efficiently with cysteine peptides, the yield of caged product 
was poor when a thiophosphorylated peptide was used (Table 
1). Therefore, we tested NBB and DMNBB, which can be 
dissolved in 95% ethanol or dimethylformamide, for reaction 
with thiophosphoryl peptides. The final concentration of or-
ganic solvent can be as low as 2%, which is tolerated by 
peptides and most proteins. Thiophosphoryl peptides were 
indeed efficiently caged by NBB and DMNBB under these 
conditions. While this work was in progress, DMNBB was 
used to cage heavy meromyosin by selective reaction at Cys-
707 in buffer containing 2% dimethylformamide [25]. 
The second consideration of efficient photolysis at benign 
wavelengths was addressed by comparing the simple 2-nitro-
benzyl chromophore with 4,5-dimethoxy-2-nitrobenzyl. This 
substitution increases the extinction coefficient at longer wave-
lengths [3,7]. However, the quantum efficiencies of photolysis 
of the 4,5-dimethoxy-2-nitrobenzyl peptides were ~ 4-fold 
lower than the 2-nitrobenzyl peptides (Table 1). Therefore, 
the beneficial effect of increased absorption ( ~ 3.2-fold with 
our lamp and filter system, emission maximum 312 nm) is 
canceled by a lower $, which has been the experience in sev-
eral related cases [7]. Nevertheless, we show that a caged 2-
nitrobenzyl thiophosphoryl peptide can be uncaged by pho-
tolysis in the presence of X-PPase. The released peptide then 
acts as a substrate for the enzyme, showing that neither the 
enzyme nor the peptide are damaged by the UV light (Fig. 4). 
The 4,5-dimethoxy-2-nitrobenzyl peptides could be useful 
where yet longer wavelengths (&360 nm) are required to pre-
vent tissue damage and 2-nitrobenzyl absorption is still weak-
er. 
The reactivities of cysteinyl and thiophosphoryl groups to-
wards NBB differ at low pH and allow the caging of thio-
phosphoryl serine in the presence of free cysteine in the same 
peptide (Fig. 2). Presumably, the cysteinyl residue (pK^-9.5) 
is protonated under these conditions, while the thiophosphor-
yl group is a reactive monoanion. We are extending this ap-
proach to thiophosphoryl proteins. In previous, and continu-
ing, attempts to cage proteins at specific sites we have focused 
on single cysteine mutants [24]. Very often this requires con-
siderable knowledge of the structure and function of the pro-
tein and the availability of numerous single cysteine candi-
dates [24]. The activities of many proteins are regulated by 
phosphorylation, which can often be mimicked by thiophos-
phorylation. Further, thiophosphorylated proteins are often 
relatively resistant to cellular phosphatases. Because, the re-
quirements for phosphorylation are quite specific, we can be 
certain that in most cases caging will block the functional 
effects of thiophosphorylation and uncaging will restore 
them. In a previous study, a fluorescent probe was attached 
to a thiophosphorylated protein, but under conditions that 
required blocking of cysteines [32]. The present approach 
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Fig. 4. Treatment of NB-caged thiophosphoryl kemptide by X-PPase 
before and after photolysis. The peptide (8 uM) was incubated for 
3 h at 30°C with A,-PPase (2000 units) in 55 ul of 50 mM Tris-HCl, 
pH 7.8, containing 5 mM DTT, 2 mM MnCl2 and 100 ug/ml bo-
vine serum albumin. (1) Thiophosphoryl kemptide (Ps-kemptide), no 
enzyme; (2) thiophosphoryl kemptide with À-PPase; (3) NB-caged 
thiophosphoryl kemptide, no UV, with X-PPase; (4) NB-caged thio-
phosphoryl kemptide, first UV treated, then treated with ^.-PPase; 
(5) NB-caged thiophosphoryl kemptide and .^-PPase UV treated to-
gether before the incubation at 30°C. 
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should be applicable to native proteins provided they are not 
irreversibly denatured or precipitated at the low p H required 
for selective modification. Shifts in the pÄTa values of cysteinyl 
and thiophosphoryl groups induced by local environments on 
proteins may facilitate or complicate selective modification 
and the reaction conditions will have to be adjusted for 
each case. 
Recognizing that the activities of many proteins are modu-
lated by phosphorylation, we envisage several applications for 
caged thiophosphoryl peptides and proteins, especially in sig-
nal transduction research. Signal transduction proteins that 
are reversibly phosphorylated in vivo include protein kinases 
and phosphatases themselves, transcription factors, G T P -
binding proteins, and proteins that bind to adaptor modules 
such as SH2 and 14-3-3 domains. Where protein-protein in-
teractions are modulated by phosphorylation, caged peptides 
(rather than proteins) may provide a means to intervene in cell 
signaling. In most cases, the peptide or protein reagent will be 
microinjected into a single cell or several cells in a collection 
of cells. Subsequent light activation will bring about activa-
tion (or in certain cases inactivation) in defined doses with 
spatial and temporal control [33]. For example, in studies of 
early development, signaling molecules might be uncaged in 
one or a few cells in an embryo. Localized activation within a 
cell will be particularly useful. In studies of neuronal modu-
lation, presynaptic or postsynaptic events might be distin-
guished from events mediated by the cell nucleus. In addition 
to cellular studies, the caging technology will be applicable in 
biophysics. For example, protein-ligand interactions or con-
formational changes of proteins might be rapidly initiated and 
then monitored by various means to obtain time-resolved 
structural information [34]. In biotherapeutics, caged peptides 
and proteins might be released in specific tissues in controlled 
doses, at defined times [35]. 
Acknowledgements: We thank John Leszyk at the W.M. Keck Protein 
Chemistry Facility at WFBR for peptide synthesis and help with 
HPLC and mass spectrometry. We are also grateful to Chung-yu 
Chang, Todd Miller and David Trentham for helpful comments. 
This work was supported by a grant from the NIH NS26760 (to 
H.B.). P.P. was supported by the NIH postdoctoral training grant 
T32 NS07366. The MALDI mass spectrometer was purchased 
through an instrumentation grant from the NSF BIR-9512226 (to 
H.B.). 
References 
[1] Gurney, A.M. and Lester, H.A. (1987) Physiol. Rev. 67, 583-617. 
[2] Morrison, H. (1993) Biological Applications of Photochemical 
Switches, Wiley, New York. 
[3] Adams, S.R. and Tsien, R.Y. (1993) Annu. Rev. Physiol. 55, 
755-784. 
[4] Kaplan, J.H. (1990) Annu. Rev. Physiol. 52, 897-914. 
[5] Makings, L.R. and Tsien, R.Y. (1994) J. Biol. Chem. 269, 6282-
6285. 
[6] Lev-Ram, V., Makings, L.R., Keitz, P.F., Kao, J.P.Y. and Tsien, 
R.Y. (1995) Neuron 15, 407-115. 
Corrie, J.E.T. and Trentham, D.R. (1993) in: Biological Appli-
cations of Photochemical Switches (Morrison, H. ed.) pp. 243-
299, Wiley, New York. 
Hess, G.P. (1993) Biochemistry 32, 989-1000. 
Fodor, S.P.A., Read, J.L., Pirrung, M.C., Stryer, L., Lu, A.T. 
and Solas, D. (1991) Science 251, 767-773. 
Reinsch, S.S., Mitchison, T.J. and Kirschner, M. (1991) J. Cell 
Biol. 115, 365-379. 
Goldmacher, V.S., Senter, P.D., Lambert, J.M. and Blättler, 
W.A. (1992) Bioconj. Chem. 3, 104-107. 
Olejnik, J., Sonar, S., Krzymañska-Olejnik, E. and Rothschild, 
K.J. (1995) Proc. Nati. Acad. Sei. USA 92, 7590-7594. 
Sundberg, S.A., Barrett, R.W., Pirrung, M., Lu, A.L., Kiang-
soontra, B. and Holmes, C.P. (1995) J. Am. Chem. Soc. 117, 
12050-12057. 
Marriott, G., Miyata, H. and Kinosita, K. (1992) Biochem. Int. 
26, 943-951. 
Marriott, G. (1994) Biochemistry 33, 9092-9097. 
Thompson, S., Spoors, J.A., Fawcett, M.-C. and Self, C.H. 
(1994) Biochem. Biophys. Res. Commun. 201, 1213-1219. 
Golan, R., Zehavi, U., Nairn, M., Patchornik, A. and Smirnoff, 
P. (1996) Biochim. Biophys. Acta 1293, 238-242. 
Self, C.H. and Thompson, S. (1996) Nature Medicine 2, 817-820. 
Willner, I. and Shai, R. (1996) Angew. Chem. Int. Ed. Engl. 35, 
367-385. 
Mendel, D., Ellman, J.A. and Schultz, P.G. (1991) J. Am. Chem. 
Soc. 113, 2758-2760. 
Cook, S.N., Jack, W.E., Xiong, X., Danley, L.E., Ellman, J.A., 
Schultz, P.G. and Noren, C.J. (1995) Angew. Chem. Int. Ed. 
Engl. 34, 1629-1630. 
Stoddard, B.L., Bruhnke, J., Porter, N., Ringe, D. and Petsko, 
G.A. (1990) Biochemistry 29, 4871^1879. 
Stoddard, B.L., Bruhnke, J., Koenigs, P., Porter, N., Ringe, D. 
and Petsko, G.A. (1990) Biochemistry 29, 8042-8051. 
Chang, C.-Y., Niblack, B., Walker, B. and Bayley, H. (1995) 
Chem. Biol. 2, 391-400. 
Marriott, G. and Heidecker, M. (1996) Biochemistry 35, 3170-
3174. 
Hazum, E., Gottlieb, P., Amit, B., Patchornik, A. and Fridkin, 
M. (1981) in: Peptides 1980. Proceedings of the Sixteenth Euro-
pean Peptide Symposium, Helsingor, Denmark (Brunfeldt, K. 
ed.) pp. 105-110, Scriptor, Copenhagen. 
Haugland, R.P. (1996) Handbook of Fluorescent Probes and 
Research Chemicals, 6th edn., Molecular Probes, Eugene, OR. 
Ulysse, L., Cubillos, J. and Chmielewski, J. (1995) J. Am. Chem. 
Soc. 117, 8466-8467. 
Kaplan, J.H., Forbush, B. and Hoffman, J.F. (1978) Biochemis-
try 17, 1929-1935. 
Walker, J.W., Reid, G.P., McCray, J.A. and Trentham, D.R. 
(1988) J. Am. Chem. Soc. 110, 7170-7177. 
Morrison, H.A. (1969) in: The Chemistry of the Nitro and Nitro-
so Groups (Feuer, H. ed.) pp. 165-213, Interscience, New York. 
Facemyer, K.C. and Cremo, C.R. (1992) Bioconj. Chem. 3, 408-
413. 
Wang, S.-H. and Augustine, G.J. (1995) Neuron 15, 755-760. 
Stoddard, B.L., Koenigs, P., Porter, N., Petratos, K., Petsko, 
G.A. and Ringe, D. (1991) Proc. Nati. Acad. Sei. USA 88, 
5503-5507. 
[35] Bayley, H., Gasparro, F. and Edelson, R. (1987) Trends Phar-
macol. Sei. 8, 138-143. 
[?: 
[s: 
[9: 
[io: 
tu 
[12: 
[is: 
[14] 
[is: 
tie: 
[17 
[is: 
[i9: 
Po: 
[21 
[22 
[23: 
[24 
[25: 
[26 
[27 
[28: 
[29 
[30: 
[31 
[32 
[33 
[34] 
